You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
未名醫藥(002581.SZ):擬設立CDMO項目上海研發與生產基地
格隆匯 06-23 21:00

格隆匯 6 月 23日丨未名醫藥(002581.SZ)公佈,公司全資子公司北大未名(合肥)生物製藥有限公司(“北大生物”)根據戰略佈局發展需要,決定設立CDMO項目上海研發與生產基地。

上海市生物醫藥產業始終保持國內領先地位,並朝着成為具有國際影響力的生物醫藥創新策源地和生物醫藥產業集羣方向發展。北大生物上海基地作為北大生物合肥基地的窗口,依託上海市及張江生物園區的資源優勢,抓緊部署CDMO項目戰略佈局,快速推進CDMO相關研發與生產的各項工作,強化研發團隊和生產能力的建設,進一步打造公司在CDMO領域的國際競爭力。

CDMO項目上海研發與生產基地設立對公司未來發展產生積極作用,但不會對公司當期經營業績產生重大影響,敬請廣大投資者注意投資風險。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account